New York, NY -- (SBWIRE) -- 01/22/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Apollo Investment Corp (NASDAQ:AINV), Houston American Energy Corporation (NYSEMKT:HUSA), Synta Pharmaceuticals Corp (NASDAQ:SNTA), Star Scientific, Inc (NASDAQ:STSI)
Apollo Investment Corp (NASDAQ:AINV) showed a volume of 1.76 million shares by the end of last trade whereas the average volume of the stock remained 1.48 million shares. The stock opened the session at $9.07 but then moved to $9.00. At that price, the stock showed a positive performance of 0.67%. Apollo Investment Corporation (Apollo Investment) is a closed-end, non-diversified management investment company that has elected to be treated as a business development company. Its investment objective is to generate current income and capital appreciation.
Will AINV Continue To Move Higher? Find Out Here
Houston American Energy Corporation (NYSEMKT:HUSA) opened the session at $0.29 and closed the session at $0.340. The stock showed a positive performance of 14.48% in previous trading session. Traded with volume of 1.76 million shares in the prior session and the average volume of the stock remained 202,815.00 shares. Houston American Energy Corp (Houston American) is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties in the United States Gulf Coast region and in South America.
For How Long HUSA will fight for Profitability? Read This Trend Analysis report
Synta Pharmaceuticals Corp (NASDAQ:SNTA) opened the session at $6.25 and closed the session at $6.34. The stock showed a positive performance of 2.76% in previous trading session. Traded with volume of 1.75 million shares in the prior session and the average volume of the stock remained 1.89 million shares. The beta of the stock remained 3.10. Synta Pharmaceuticals Corp. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing small molecule drugs to severe the medical conditions of the patients with cancer and inflammatory diseases.
Why Should Investors Buy SNTA After The Recent Gain? Just Go Here and Find Out
Star Scientific, Inc (NASDAQ:STSI) the stock decreased -3.96% and finished the session at $0.951. Traded with volume of 1.76 million shares in the prior session and the average volume of the stock remained 1.50 million shares. The beta of the stock remained 2.35. Star Scientific, Inc. (Star Scientific) is engaged in the manufacturing and production of dietary supplements. The Company’s operating subsidiaries manufacture, distribute and sell consumer products and dietary supplements. Its segment includes dietary supplements.
Will STSI Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)